Online citations, reference lists, and bibliographies.
← Back to Search

Tremelimumab As Second-line Or Third-line Treatment In Relapsed Malignant Mesothelioma (DETERMINE): A Multicentre, International, Randomised, Double-blind, Placebo-controlled Phase 2b Trial

Michele Maio, Arnaud Scherpereel, Luana Calabrò, Joachim Aerts, Susana Cedres Perez, Alessandra Bearz, Kristiaan Nackaerts, Dean A Fennell, Dariusz Kowalski, Anne S Tsao, Paul Taylor, Federica Grosso, Scott J Antonia, Anna K Nowak, Maria Taboada, Martina Puglisi, Paul K Stockman, Hedy L Kindler

Cite This
Download PDF
Analyze on Scholarcy
Share